A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block

NCT02850484 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma
Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Budesonide
DRUG: Formoterol

Sponsor

Intech Biopharm Ltd.